MHC PEPTIDES OVER-EXPRESSED ON PROSTATE CANCER CELLS AND METHODS OF USE - Patent 1303287

(19)

(11)

EP 1 303 287 A1

(12)

(43)	Date of publication:
	23.04.2003 Bulletin 2003/17

(21)	Application number: 01942207.0

(22)	Date of filing: 15.06.2001

(51)	International Patent Classification (IPC)⁷: A61K 38/00, A61K 38/04, A61K 39/395, A61K 39/00, A01N 63/00, C07K 7/00, C07K 16/00, C12N 5/06, C12N 5/08

(86)	International application number:
	PCT/US0119/207

(87)	International publication number:
	WO 0109/7827 (27.12.2001 Gazette 2001/52)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

16.06.2000 US 212213 P
16.06.2000 US 212165 P

(71)	Applicants:
	Argonex Pharmaceuticals Charlottesville, VA 22903 (US) UNIVERSITY OF VIRGINIA PATENT FOUNDATION Charlottesville,Virginia 22903 (US)

(72)	Inventors:
	WHITE, Forest Charlottesville, VA 22911 (US) HUNT, Donald, F. Charlottesville, VA 22901 (US) SHABANOWITZ, Jeffrey Charlottesville, VA 22901 (US)

(74)	Representative: Ruffles, Graham Keith
	MARKS & CLERK,57-60 Lincoln's Inn Fields London WC2A 3LS London WC2A 3LS (GB)

(54)	MHC PEPTIDES OVER-EXPRESSED ON PROSTATE CANCER CELLS AND METHODS OF USE